News articles

News article list

• Hundreds of people with some forms of urothelial cancer to receive new treatment

  People with locally advanced or metastatic urothelial cancer are set to benefit from a new treatment – avelumab – following its recommendation for funding

• NICE calls for further research into the treatment of chronic lipoedema

  NICE has today issued interventional procedures guidance on the use of liposuction for the treatment of chronic lipoedema.

• NICE publishes comprehensive quality standard designed to improve the diagnosis and assessment of fetal alcohol spectrum disorder

  NICE’s latest quality standard published today (16 March 2022) helps improve the diagnosis, assessment, and prevention of fetal alcohol spectrum disorder (FASD).

• Pembrolizumab plus chemotherapy not recommend for triple negative breast cancer

  Draft guidance published today (8 March 2022) by NICE does not recommend pembrolizumab plus chemotherapy for treating triple negative breast cancer

• Over 500 people a year can access a new life extending lung cancer treatment

  An innovative life-extending drug for treating mutation-positive locally advanced or metastatic non-small-cell lung cancer (NSCLC) in adults is being recommended by NICE as an option for use within the Cancer Drugs Fund.

• Around 400 people with advanced breast cancer are set to benefit from a new treatment

  Tucatinib works by blocking a specific area of the HER2 gene in cancer cells, which stops the cells from growing and spreading.